Prestige Consumer Healthcare PBH Balance Sheet Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $63.87M+2.4% | $62.37M-47.6% | $119.11M-14.6% | $139.5M+42.5% | $97.88M+92.4% | ||
| $191.92M+0.8% | $190.46M-4.3% | $199M+18.2% | $168.41M-13.3% | $194.29M+16.2% | ||
| $159.13M-2.7% | $163.59M+2.9% | $159M+3.8% | $153.13M+3.7% | $147.71M-2.5% | ||
| $431.48M-0.4% | $433.43M-12.9% | $497.41M+3.5% | $480.52M+7.2% | $448.33M+18.9% | ||
| $121.69M-5.1% | $128.21M+75.4% | $73.1M-0.9% | $73.79M-1.0% | $74.55M+1.4% | ||
| $581.11M0.0% | $581.25M+10.0% | $528.41M0.0% | $528.31M+0.2% | $527.43M0.0% | ||
| $2.3B+1,338% | $159.93M+6.4% | $150.29M-2.8% | $154.65M-93.3% | $2.3B+1,538% | ||
| $3.49B0.0% | $3.49B+1.5% | $3.44B+0.3% | $3.43B+0.9% | $3.4B+2.2% | ||
| $22.79M-46.9% | $42.95M+2.4% | $41.92M+88.8% | $22.21M+17.3% | $18.93M-3.0% | ||
| $2.66M+1.6% | $2.61M+1.6% | $2.57M+1.7% | $2.53M+1.6% | $2.49M+177% | ||
| $120.92M-13.4% | $139.56M+3.7% | $134.6M+22.7% | $109.67M+2.9% | $106.62M+4.0% | ||
| $993.95M-3.8% | $1.03B+4.1% | $993.15M0.0% | $992.75M0.0% | $992.36M-0.8% | ||
| $1.61B-3.5% | $1.67B+3.0% | $1.62B+2.6% | $1.58B+0.6% | $1.57B+1.7% | ||
| $562K-99.8% | $250M0.0% | $250M0.0% | $250M+44,543% | $560K-99.8% | ||
| $1.75B+3.2% | $1.69B+2.8% | $1.65B+2.6% | $1.6B+3.1% | $1.56B+3.3% | ||
| $1.89B+3.2% | $1.83B+0.2% | $1.82B-1.6% | $1.86B+1.1% | $1.83B+2.6% | ||
| $3.49B0.0% | $3.49B+1.5% | $3.44B+0.3% | $3.43B+0.9% | $3.4B+2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Prestige Consumer Healthcare cover its short-term obligations?
- Its current ratio is 3.57 — current assets exceed current liabilities.
- Where does Prestige Consumer Healthcare's balance sheet data come from?
- Every line is extracted from Prestige Consumer Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.